PTGX - Protagonist Therapeutics Inc

Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.

52W High

$61.89

52W Low

$33.31

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.22

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

82.92

Forward P/E (<15 better)

26.39

EV/EBITDA (<8 favorable)

119.47

EV/Revenue (<3 favorable)

15.33

P/S (TTM) (<3 favorable)

18.00

P/B (<3 favorable)

5.64

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.03%

Institutions (25–75% balanced)

116.26%

Shares Outstanding

62,211,000

Float

43,159,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

209,180,000

Gross Profit (TTM)

209,180,000

EPS (TTM)

0.73

Profit Margin (>10% good)

0.25%

Operating Margin (TTM) (higher better)

-7.58%

ROE (TTM) (>15% strong)

0.09%

EPS YoY (Quarterly) (>10% good)

3.51

Revenue YoY (Quarterly) (>8% good)

0.33

Momentum

Bearish momentum

Value

1.7140

1.5816

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025